Opposite ends of spectrumOne end - MCNA is so good, it is the probable holy grail of cancer treatments for many cancers. Remember Santa said that in the lab they couldn't find a cancer it didn't kill. It also, in a variant form, restores white blood cell count back to normal very quickly after chemo has killed those levels. With the right funding and partner in the USA, many trials will start in the next 3 years. There are so many billion$$$$ to be made here, that this is the reason for all the shenanigans that have been going on here for many years, from the 'disidents' taking over, to the 108million shares last summer, and the OS going from 75mil when I first got involved, to +300mil now, and less market cap at that. The potential is so great that they could not let this be a success with mostly retail holders. My bet is that right now we have +90% non retail. Soon the stock price will climb to eclipse all previous 10 year highs, as the FDA first gives limited approval for a small population, and that will be the start of the major climb, and the few retailers left will make a small fortune in %age terms. Look for a $bil buyout.
Other end - FDA continues to play hardball, requiring major new trials which no one will fund. TST continues on a downward spiral til someone picks up the crumbs, or privatizes, denying the retail guy any spoils at all. MCNA will still be approved, but the money is made by the entities that are currently playing games and stealing shares from retailers.
Most likely the end result will be about one rung on the ladder from the worst case scenario, giving us peons a few crumbs only.